Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Mölken MR"'
Autor:
Koleva-Kolarova, R, Buchanan, J, Vellekoop, H, Huygens, S, Versteegh, M, Mölken, MR-V, Szilberhorn, L, Zelei, T, Nagy, B, Wordsworth, S, Tsiachristas, A, Consortium, HEcoPerMed
Publikováno v:
Applied Health Economics and Health Policy. 20(4):501-524
Background: The number of healthcare interventions described as ‘personalised medicine’ (PM) is increasing rapidly. As healthcare systems struggle to decide whether to fund PM innovations, it is unclear what models for financing and reimbursement
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbd7a142063744f8e7dc391e2c9cb38e
http://www.scopus.com/inward/record.url?scp=85130475829&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85130475829&partnerID=8YFLogxK
Autor:
Santi I; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Burgemeester Oudlaan 50, 3062 PA, Rotterdam, The Netherlands. irene.santi@santinsights.nl., Vellekoop H; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Burgemeester Oudlaan 50, 3062 PA, Rotterdam, The Netherlands., M Versteegh M; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Burgemeester Oudlaan 50, 3062 PA, Rotterdam, The Netherlands., A Huygens S; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Burgemeester Oudlaan 50, 3062 PA, Rotterdam, The Netherlands., Dinjens WNM; Department of Pathology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Mölken MR; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Burgemeester Oudlaan 50, 3062 PA, Rotterdam, The Netherlands.; School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Publikováno v:
Molecular diagnosis & therapy [Mol Diagn Ther] 2024 May; Vol. 28 (3), pp. 319-328. Date of Electronic Publication: 2024 Apr 14.
Autor:
Szilberhorn L; Syreon Research Institute, 1142, Budapest, Hungary., Zelei T; Syreon Research Institute, 1142, Budapest, Hungary., Vellekoop H; Institute for Medical Technology Assessment, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands., Huygens S; Institute for Medical Technology Assessment, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands., Versteegh M; Institute for Medical Technology Assessment, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands., Mölken MR; Institute for Medical Technology Assessment, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands.; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands., Koleva-Kolarova R; Health Economics Research Centre, University of Oxford, OX3 7LF, Oxford, UK., Tsiachristas A; Health Economics Research Centre, University of Oxford, OX3 7LF, Oxford, UK., Wordsworth S; Health Economics Research Centre, University of Oxford, OX3 7LF, Oxford, UK., Nagy B; Syreon Research Institute, 1142, Budapest, Hungary.; Center for Health Technology Assessment, Semmelweis University, 1091, Budapest, Hungary.
Publikováno v:
Personalized medicine [Per Med] 2023 Jul; Vol. 20 (4), pp. 387-399. Date of Electronic Publication: 2023 Sep 04.
Autor:
Nagy B; Syreon Research Institute, Budapest, Hungary.; Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary., Zelei T; Syreon Research Institute, Budapest, Hungary., Vellekoop H; Institute for Medical Technology Assessment, Erasmus University Rotterdam, 3000 DR, Rotterdam, The Netherlands., Huygens S; Institute for Medical Technology Assessment, Erasmus University Rotterdam, 3000 DR, Rotterdam, The Netherlands., Versteegh M; Institute for Medical Technology Assessment, Erasmus University Rotterdam, 3000 DR, Rotterdam, The Netherlands., Mölken MR; Institute for Medical Technology Assessment, Erasmus University Rotterdam, 3000 DR, Rotterdam, The Netherlands.; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands., Koleva-Kolarova R; Health Economics Research Centre, University of Oxford, Oxford, UK., Tsiachristas A; Health Economics Research Centre, University of Oxford, Oxford, UK., Wordsworth S; Health Economics Research Centre, University of Oxford, Oxford, UK., Szilberhorn L; Syreon Research Institute, Budapest, Hungary.
Publikováno v:
Personalized medicine [Per Med] 2023 Jul; Vol. 20 (4), pp. 401-411. Date of Electronic Publication: 2023 Sep 11.
Autor:
Koleva-Kolarova R; Health Economics Research Centre, University of Oxford, Oxford, UK., Szilberhorn L; Syreon Research Institute, Budapest, Hungary.; Faculty of Social Sciences, Eötvös Loránd University, Budapest, Hungary., Zelei T; Syreon Research Institute, Budapest, Hungary., Vellekoop H; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands., Nagy B; Syreon Research Institute, Budapest, Hungary., Huygens S; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands., Versteegh M; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands., Mölken MR; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands.; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands., Wordsworth S; Health Economics Research Centre, University of Oxford, Oxford, UK., Tsiachristas A; Health Economics Research Centre, University of Oxford, Oxford, UK.
Publikováno v:
Personalized medicine [Per Med] 2023 Jul; Vol. 20 (4), pp. 305-319. Date of Electronic Publication: 2023 Aug 25.
Autor:
Koleva-Kolarova R; Health Economics Research Centre, University of Oxford, Oxford, UK., Vellekoop H; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands., Huygens S; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands., Versteegh M; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands., Mölken MR; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands.; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands., Szilberhorn L; Syreon Research Institute, Budapest, Hungary.; Faculty of Social Sciences, Eötvös Loránd University, Budapest, Hungary., Zelei T; Syreon Research Institute, Budapest, Hungary., Nagy B; Syreon Research Institute, Budapest, Hungary., Wordsworth S; Health Economics Research Centre, University of Oxford, Oxford, UK.; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK., Tsiachristas A; Health Economics Research Centre, University of Oxford, Oxford, UK.; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK.
Publikováno v:
Personalized medicine [Per Med] 2023 Jul; Vol. 20 (4), pp. 339-355. Date of Electronic Publication: 2023 Sep 04.
Autor:
Koleva-Kolarova R; Health Economics Research Centre, University of Oxford, Oxford, UK., Vellekoop H; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands., Huygens S; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands., Versteegh M; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands., Mölken MR; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands.; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands., Szilberhorn L; Syreon Research Institute, Budapest, Hungary.; Eötvös Loránd University, Budapest, Hungary., Zelei T; Syreon Research Institute, Budapest, Hungary., Nagy B; Syreon Research Institute, Budapest, Hungary., Wordsworth S; Health Economics Research Centre, University of Oxford, Oxford, UK.; National Institute for Health Research Oxford Biomedical Research Centre, Oxford, UK., Tsiachristas A; Health Economics Research Centre, University of Oxford, Oxford, UK.; National Institute for Health Research Oxford Biomedical Research Centre, Oxford, UK.
Publikováno v:
Personalized medicine [Per Med] 2023 Jul; Vol. 20 (4), pp. 357-374. Date of Electronic Publication: 2023 Aug 14.
Autor:
Kovács G; Syreon Research Institute, Budapest, 1142, Hungary., Nagy D; Syreon Research Institute, Budapest, 1142, Hungary., Szilberhorn L; Syreon Research Institute, Budapest, 1142, Hungary., Zelei T; Syreon Research Institute, Budapest, 1142, Hungary., Gaál Z; Fourth Department of Medicine, Jósa András Teaching Hospital, Nyíregyháza, 4400, Hungary., Vellekoop H; Institute for Medical Technology Assessment, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands., Huygens S; Institute for Medical Technology Assessment, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands., Versteegh M; Institute for Medical Technology Assessment, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands., Mölken MR; Institute for Medical Technology Assessment, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands.; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, P.O. Box 17383000 DR, Rotterdam, The Netherlands., Koleva-Kolarova R; Health Economics Research Centre, University of Oxford, Oxford, OX3 7LF, UK., Tsiachristas A; Health Economics Research Centre, University of Oxford, Oxford, OX3 7LF, UK., Wordsworth S; Health Economics Research Centre, University of Oxford, Oxford, OX3 7LF, UK., Nagy B; Syreon Research Institute, Budapest, 1142, Hungary.; Center for Health Technology Assessment, Semmelweis University, Budapest, 1091, Hungary.
Publikováno v:
Personalized medicine [Per Med] 2023 Jul; Vol. 20 (4), pp. 375-385. Date of Electronic Publication: 2023 Sep 11.
Autor:
Herranz C; Consorci d'Atenció Primària de Salut de L'Eixample (CAPSBE), Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain., González-Colom R; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain., Baltaxe E; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Institute of Pulmonary Medicine, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel., Seijas N; Hospital Clínic de Barcelona, Villarroel 170, 08036, Barcelona, Spain., Asenjo M; Hospital Clínic de Barcelona, Villarroel 170, 08036, Barcelona, Spain., Hoedemakers M; Erasmus School of Health Policy and Management and Institute for Medical Technology Assessment, Erasmus University Rotterdam. Rotterdam, The Netherlands, Rotterdam, Netherlands., Nicolas D; Hospital Clínic de Barcelona, Villarroel 170, 08036, Barcelona, Spain., Coloma E; Hospital Clínic de Barcelona, Villarroel 170, 08036, Barcelona, Spain., Fernandez J; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Hospital Clínic de Barcelona, Villarroel 170, 08036, Barcelona, Spain., Vela E; Àrea de Sistemes d'Informació. Digitalization for the Sustainability of the Healthcare System (DS3), Servei Català de La Salut, Barcelona, Spain., Cano I; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain., Mölken MR; Erasmus School of Health Policy and Management and Institute for Medical Technology Assessment, Erasmus University Rotterdam. Rotterdam, The Netherlands, Rotterdam, Netherlands., Roca J; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Hospital Clínic de Barcelona, Villarroel 170, 08036, Barcelona, Spain., Hernandez C; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. chernan@clinic.cat.; Hospital Clínic de Barcelona, Villarroel 170, 08036, Barcelona, Spain. chernan@clinic.cat.
Publikováno v:
BMC health services research [BMC Health Serv Res] 2022 Sep 07; Vol. 22 (1), pp. 1133. Date of Electronic Publication: 2022 Sep 07.
Autor:
Hoogendoorn M; Institute for Medical Technology Assessment (IMTA), Erasmus University Rotterdam, Rotterdam, The Netherlands. Electronic address: hoogendoorn@imta.eur.nl., Jowett S; Health Economics Unit, University of Birmingham, Birmingham, England, UK., Dickens AP; Institute of Applied Health Research, University of Birmingham, Birmingham, England, UK., Jordan R; Institute of Applied Health Research, University of Birmingham, Birmingham, England, UK., Enocson A; Institute of Applied Health Research, University of Birmingham, Birmingham, England, UK., Adab P; Institute of Applied Health Research, University of Birmingham, Birmingham, England, UK., Versteegh M; Institute for Medical Technology Assessment (IMTA), Erasmus University Rotterdam, Rotterdam, The Netherlands., Mölken MR; Institute for Medical Technology Assessment (IMTA), Erasmus University Rotterdam, Rotterdam, The Netherlands; Erasmus School of Health Policy and Management (ESHPM), Erasmus University Rotterdam, Rotterdam, The Netherlands.
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2021 Nov; Vol. 24 (11), pp. 1667-1675. Date of Electronic Publication: 2021 Aug 04.